Next Article in Journal
Ammonium Salts of 5-(3-Chromenyl)-5H-chromeno[2,3-b]pyridines
Previous Article in Journal
Dichloro(η6-p-cymene)(P,P-diphenyl-N-propyl-phosphinous amide-κP)ruthenium(II)
Short Note

5-Ethoxy-1-(4-methoxyphenyl)-5-methyl-3-phenylimidazolidine-2,4-dione

Department of Organic Chemistry, Faculty of Pharmacy, University of the Basque Country, UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain
*
Authors to whom correspondence should be addressed.
Academic Editor: Raffaella Mancuso
Molbank 2021, 2021(2), M1218; https://doi.org/10.3390/M1218
Received: 29 April 2021 / Revised: 7 May 2021 / Accepted: 11 May 2021 / Published: 28 May 2021
(This article belongs to the Section Organic Synthesis)

Abstract

The title compound is a hydantoin derivative that has been synthesized through a three-component reaction of ethyl pyruvate, p-anisidine and phenyl isocyanate. This paper provides a comprehensive spectral dataset for the title compound, including 1H and 13C{1H} NMR, IR, HRMS, and X-ray crystallography analyses. A tentative mechanism comprising two complementary pathways is provided based on additional experiments with the preformed intermediates.
Keywords: multicomponent reactions; hydantoins; heterocycles multicomponent reactions; hydantoins; heterocycles

1. Introduction

Hydantoins are important nitrogen heterocyclic compounds that have been known for more than a century, since their discovery by Adolf von Baeyer in 1861 [1]. Structurally related to barbiturates, hydantoins are efficient calcium channel blockers, and for this reason they are mainly used in medicine as anticonvulsant drugs, such as in the case of phenytoin, phosphenytoin or ethotoin (Figure 1) [2,3,4]. In addition, numerous hydantoin derivatives show assorted biological activities such as antidiabetic [5], antiulceric [6], antiarrhythmic [7], antimicrobial [8], antiviral [9] or antitumoral [10] ones and are also used in agrochemistry as herbicidal and antifungal agents [11,12,13].
Traditionally, Bucherer–Bergs [14], Urech [15] and Biltz [16] reactions are used for the formation of the hydantoin skeleton, starting from ketones or aldehydes, aminoacid derivatives or dicarbonylic compounds, respectively (Scheme 1), but in the last century a wide number of alternative methods for the construction of the hydantoin scaffold have been reported [17,18,19,20]. In particular, much attention has been paid to to the development of multicomponent protocols to access the hydantoin heterocycle [21,22,23,24]. These multicomponent approaches have many benefits in comparison with stepwise reactions, including their step efficiency, atom economy, high exploratory power and convergence, and, in addition, they are ideally suited for an environmentally friendly synthesis [25,26].
In this context, a few years ago, we described a Brönsted acid-catalyzed multicomponent synthesis of dihydropyrrolones starting from amines, aldehydes and pyruvate derivatives [27]. More recently, we have reported the enantioselective version of such a reaction, using chiral phosphoric acids [28], and next we have extended the reaction to the use of acetylene carboxylates instead of pyruvate derivatives [29]. Moreover, the scope of the reaction has been expanded to the synthesis of the phosphorus and fluorine substituted substrates [30]. Continuing with our interest in the applications of multicomponent reactions for the synthesis of heterocyclic substrates, herein we report a pyruvate-based three-component reaction for the synthesis of a hydantoin derivative holding a tetrasubstituted stereocenter.

2. Results and Discussion

The overnight reaction of ethyl pyruvate 1, p-anisidine 2 and phenyl isocyanate 3 in the presence of sodium hydroxide in refluxing chloroform affords hydantoin derivative 4 in a good yield after purification by column chromatography and crystallization from diethyl ether (Scheme 2).
Hydantoin derivative 4 was fully characterized on the basis of its 1H and 13C{1H} NMR, DEPT and IR spectra and HRMS (see ESI). One of the most characteristic signals for substrate 4 in the 1H NMR spectrum (CD3OD) is the ethoxy group, which is seen as two representative double quartets at δH = 3.53 ppm (2JHH = 8.4 Hz, 3JHH = 7.0 Hz) and δH = 3.85 ppm (2JHH = 8.4 Hz, 3JHH = 7.0 Hz), typical for a diastereotopic methylene group in an ethyl moiety. The methyl substituent at the 5-membered heterocycle appears as a singlet at δH = 1.52 ppm, in the typical range for a methyl group of a quaternary carbon.
Likewise, in the 13C NMR spectrum of hydantoin 4, the quaternary stereogenic carbon presents a chemical shift at δC = 86.1 ppm, and its ethoxy and methyl substituents can be detected by the chemical shifts at δC = 11.1 and 55.8 ppm and δC = 17.8 ppm, respectively. The urea and amide type carbonyl groups are in this case seen at δC = 149.5 and 166.3 ppm. The substitution of the carbon atoms was verified by Distortionless Enhancement by Polarization Transfer (DEPT) experiments.
The IR spectrum of hydantoin 4 shows several absorptions in the interval ν = 3054–2911 cm−1 corresponding to the stretching vibration of aromatic and aliphatic C–H bonds, and the overtones of the aromatic rings in the area at ν = 2356–2302 cm−1. The most relevant absorption observed in the IR spectrum corresponds to the stretching of amide and urea C=O bonds at ν =1728 cm−1. The vibration of aromatic C–C bonds results in a strong absorption at ν = 1511 cm−1, and the stretching vibration of the C–N bond is manifested as an absorption at ν = 1406 cm−1. Due to the presence of the ethoxy group, the IR spectrum shows a doublet and a multiplet for the asymmetric and symmetric stretching bonds of the C–O–C bonds at ν = 1252 and 1049 cm−1, respectively.
Moreover, the high-resolution mass spectrometry experiment shows a single peak corresponding to a molecular ion with an exact mass of 341.1504 amu that fits with the predicted mass of the calculated molecular formula far within the standard tolerated deviation.
In order to unequivocally determine the identity of hydantoin 4, a monocrystal was isolated from a mixture of CH2Cl2/hexanes, and then an X-ray diffraction analysis was performed to clearly confirm the structure of substrate 4 (Figure 2). Key features of the crystal structure of hydantoin 4 are the planar arrangement of the 5-membered heterocycle, as expected by the presence of two carbonyl sp2 carbons, which are conjugated with the two nitrogen atoms, and the twisted conformation of both aromatic substituents in order to minimize the steric interactions with the carbonyl and the ethoxy and methy groups.
Based on the determined structure of hydantoin substrate 4, we propose two complementary mechanisms for the three-component process (Scheme 3). In the first of our proposals, p-anisidine 2 and phenyl isocyanate 3 are combined to form urea derivative 5, which, by means of a condensation reaction between the most nucleophilic nitrogen of the urea substrate and the ketone functionality of ethyl pyruvate 4, leads to the formation of α-enaminoester 8. Next, a nucleophilic addition of the second nitrogen of the urea to the ester moiety would afford methylene-hydantoin species 9 with the loss of ethanol. Then, the acid-base isomerization of the enamine functional group in 9 leads to iminium species 10, which is stabilized by the presence of an ethoxide anion, whose formation is favored by the presence of sodium hydroxide. Finally, the ethoxide nucleophile anion undergoes a nucleophilic addition to the iminium moiety to afford hydantoin substrate 4. In the second proposal, enamine intermediate 8 arises from an initial amine-carbonyl condensation of ethyl pyruvate 1 and p-anisidine 3, leading to enamine 6, followed by a subsequent nucleophilic addition of the enamine nucleophile to phenyl isocyanate 3. In view of the fact that if the reaction is carried out with the preformation of the intermediate urea 5 or enamine 6, hydantoin substrate 4 is equally obtained, we conclude that both mechanisms are indeed implied in this transformation.

3. Materials and Methods

3.1. General Experimental Information

Solvents for extraction and chromatography were technical grade. All solvents used in reactions were freshly distilled from appropriate drying agents before use. All other reagents were recrystallized or distilled as necessary. All reactions were performed under an atmosphere of dry nitrogen. Analytical TLC was performed with silica gel 60 F254 plates. Visualization was accomplished by UV light. 1H, and 13C-NMR spectra were recorded on a Varian Unity Plus (Varian Inc., NMR Systems, Palo Alto, Santa Clara, CA, USA) (at 300 MHz, 75 MHz, 120 MHz and 282 MHz, respectively) and on a Bruker Avance 400 (Bruker BioSpin GmbH, Rheinstetten, Germany) (at 400 MHz for 1H and 100 MHz for 13C). Chemical shifts (δ) are reported in ppm relative to residual CHCl3 (δ = 7.26 ppm for 1H and δ = 77.16 ppm for 13C NMR). Coupling constants (J) are reported in Hertz. Data for 1H NMR spectra are reported as follows: chemical shift, multiplicity, coupling constant, integration. Multiplicity abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. 13C NMR peak assignments were supported by distortionless enhanced polarization transfer (DEPT). High resolution mass spectra (HRMS) were obtained by positive-ion electrospray ionization (ESI). Data are reported in the form m/z (intensity relative to base = 100). Infrared spectra (IR) were taken in a Nicolet iS10 Thermo Scientific spectrometer (Thermo Scientific Inc., Waltham, MA, USA) as neat solids. Peaks are reported in cm−1.

3.2. Experimental Procedures and Characterization Data for Hydantoin 4

A solution of ethyl pyruvate (116 mg, 111 μL, 1 mmol), p-anisidine (123 mg, 1 mmol) and phenyl isocyanate (119 mg, 109 μL, 1 mmol) in CHCl3 (3 mL) was stirred under reflux overnight in the presence of NaOH (80 mg, 2 mmol). The reaction was washed with water (2 × 5 mL), and the organic layer was dried over MgSO4 and concentrated under vacuum. The resulting crude residue was purified by column chromatography (AcOEt/Hexanes 5:95) followed by crystallization from Et2O, affording 271 mg of hydantoin 4 (79%) as a white solid. M.p.: 140–142 °C. 1H-NMR (400 MHz, CDCl3) δ 7.53–7.44 (m, 5H, 5 × CHAr, Ph), 7.36 (d, 3JHH = 9.1 Hz, 2H, 2 × CHAr, p-CH3OC6H4), 7.02 (d, 3JHH = 9.1 Hz, 2H, 2 × CHAr, p-CH3OC6H4), 3.85 (dq, 2JHH = 8.4 Hz, 3JHH = 7.0 Hz, 1H, CH2, OEt), 3.84 (s, 3H, CH3O), 3.53 (dq, 2JHH = 8.4 Hz, 3JHH = 7.0 Hz, 1H, CH2, OEt), 1.52 (s, 3H, CH3), 1.31 (dd, 3JHH = 7.0 Hz, 3JHH = 7.0 Hz, 3H, CH3, OEt) ppm. 13C-NMR {1H} (101 MHz, CDCl3) δ 166.3 (NC=O), 155.0 (CquatO, p-CH3OC6H4), 149.5 (NC=ON), 127.4 (CquatN, Ph), 125.4 (2 × CHAr, Ph), 124.7 (CHAr, Ph), 123.4 (2 × CHAr, Ph),122.8 (CquatN, p-CH3OC6H4), 122.4 (2 × CHAr, p-CH3OC6H4), 110.8 (2 × CHAr, p-CH3OC6H4), 55.8 (OCH2, OEt), 51.8 (OCH3, p-CH3OC6H4), 17.8 (CH3), 11.1 (CH3, OEt) ppm. FTIR (neat) νmax: 3054 (Ar-H st), 2980–2911 (Alk-H st), 2356–2302 (ar comb), 1728 (C=O st), 1511 (ar C–C), 1406 (C–N st), 1252 (d, C–O–C st, as), 1049 (m, C–O–C st, sy), 737 (=C–H δ oop), 701 (d, CH2 γ) cm−1. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C32H48N2O9 341.1501, Found 341.1504. Crystal Data for C19H20N2O4 (M = 340.37 g/mol): monoclinic, space group P21/c (no. 14), a = 12.55957(12) Å, b = 10.65990(12) Å, c = 13.02617(14) Å, a = 90.0°, β = 99.1587(10)°, g = 90.0°, V = 1721.76(3) Å3, Z = 4, T = 150.00(10) K, μ(CuKα) = 0.763 mm−1, rcalc = 1.313 g/cm3, 30,974 reflections measured (7.13° ≤ 2Θ ≤ 137.908°), 3188 unique (Rint = 0.0355, Rsigma = 0.0146) which were used in all calculations. The final R1 was 0.0470 (I > 2σ(I)) and wR2 was 0.1155 (all data). CCDC Deposition number: 2080208.

4. Conclusions

The synthesis of hydantoin derivative 4 is accomplished by a three-component reaction of ethyl pyruvate, p-anisidine and phenyl isocyanate. 1H and 13C{1H} NMR, IR, HRMS and X-ray crystallography analyses unequivocally confirm the identity of the title compound. Moreover, two complementary pathways for the mechanism of the formation of hydantoin 4 are provided on the basis of additional experiments starting from the preformed intermediates.

Supplementary Materials

1H and 13C-NMR, IR and HRMS spectra, ortep drawing, cif file and mol file of compound 4.

Author Contributions

Conceptualization, A.L.-F., X.d.C., E.M.d.M., F.P. and J.V.; methodology, A.L.-F. and X.d.C.; software, A.L.-F. and X.d.C.; validation, E.M.d.M. and J.V.; formal analysis, A.L.-F. and X.d.C.; investigation, A.L.-F. and X.d.C.; resources, E.M.d.M., F.P. and J.V.; data curation, A.L.-F. and X.d.C.; writing—original draft preparation, J.V.; writing—review and editing, A.L.-F., X.d.C., E.M.d.M., F.P. and J.V.; visualization, E.M.d.M., F.P. and J.V.; supervision, E.M.d.M. and J.V.; project administration, E.M.d.M. and J.V.; funding acquisition, E.M.d.M., F.P. and J.V. All authors have read and agreed to the published version of the manuscript.

Funding

Financial support by Ministerio de Economía, Industria y Competividad (MINECO, CTQ-2015-67871R) and Gobierno Vasco (GV, IT 992-16) is gratefully acknowledged. X.d.C. and A.L.-F. thank the Basque Country Government for a predoctoral grant.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the supplementary materials file or on request from the corresponding author (1H and 13C-NMR, IR and HRMS spectra, ortep drawing and cif file).

Acknowledgments

The authors thank SGIker (UPV/EHU/ERDF, EU) for providing technical and human support.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are available from the corresponding author.

References

  1. Baeyer, A. Beiträge zur Kenntniss der Harnsäuregruppe. Justus Liebigs Ann. Chem. 1861, 119, 126–128. [Google Scholar] [CrossRef]
  2. LoVecchio, F. Hydantoin Anticonvulsants: Phenytoin and Fosphenytoin. In Synthesis of Essential Drugs; Brent, J., Burkhart, K., Dargan, P., Hatten, B., Mégarbane, B., Palmer, R., White, J., Eds.; Springer International Publishing: Basel, Switzerland, 2017. [Google Scholar] [CrossRef]
  3. Brown, M.L.; Brown, G.B.; Brouillette, W.J. Effects of log P and phenyl ring conformation on the binding of 5-phenylhydantoins to the voltage-dependent sodium channel. J. Med. Chem. 1997, 40, 602–607. [Google Scholar] [CrossRef]
  4. Vardanyan, R.S.; Hruby, V.J. (Eds.) Antiepileptic Drugs. In Critical Care Toxicology; Elsevier: Amsterdam, The Netherlands, 2006; pp. 125–133. [Google Scholar] [CrossRef]
  5. Volonterio, A.; Ramirez de Arellano, C.; Zanda, M. Synthesis of 1,3,5-Trisubstituted Hydantoins by Regiospecific Domino Condensation/Aza-Michael/O→N Acyl Migration of Carbodiimides with Activated α,β-Unsaturated Carboxylic Acids. J. Org. Chem. 2005, 70, 2161–2170. [Google Scholar] [CrossRef] [PubMed]
  6. Zhang, D.; Ye, D.; Feng, E.; Wang, J.; Shi, J.; Jiang, H.; Liu, H. Highly α-Selective Synthesis of Sialyl Spirohydantoins by Regiospecific Domino Condensation/O→N Acyl Migration/N-Sialylation of Carbodiimides with Peracetylated Sialic Acid. J. Org. Chem. 2010, 75, 3552–3557. [Google Scholar] [CrossRef]
  7. Brouillette, Y.; Lisowski, V.; Guillon, J.; Massip, S.; Martinez, J. Efficient one-pot microwave-assisted synthesis of 3-(thien-3-yl)imidazolidine-2,4-dione analogs. Tetrahedron 2007, 63, 7538–7544. [Google Scholar] [CrossRef]
  8. Mandal, A.; Krishnan, R.S.G.; Thennarasu, S.; Panigrahi, S.; Mandal, A.B. Two-dimensional surface properties of an antimicrobial hydantoin at the air–water interface: An experimental and theoretical study. Colloids Surf. B 2010, 79, 136–141. [Google Scholar] [CrossRef]
  9. Todorov, P.T.; Naydenova, E.D. Synthesis and characterization of novel dipeptide mimetics with hydantoin moiety. C. R. Chim. 2010, 13, 1424–1428. [Google Scholar] [CrossRef]
  10. Kumar, C.A.; Swamy, S.N.; Sugahara, K.; Rangappa, K.S. Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells. Bioorg. Med. Chem. 2009, 17, 4928–4934. [Google Scholar] [CrossRef]
  11. Gong, Y.D.; Sohn, H.Y.; Kurth, M.J. Microwave-Mediated Intramolecular Carbanilide Cyclization to Hydantoins Employing Barium Hydroxide Catalysi. J. Org. Chem. 1998, 63, 4854–4856. [Google Scholar] [CrossRef]
  12. Alizadeh, A.; Sheikhi, E. One-pot synthesis of functionalized hydantoin derivatives via a four-component reaction between an amine, an arylsulfonyl isocyanate and an alkyl propiolate or dialkyl acetylenedicarboxylate in the presence of triphenylphosphine. Tetrahedron Lett. 2007, 48, 4887–4890. [Google Scholar] [CrossRef]
  13. Marton, J.; Enisz, J.; Hosztafi, S.; Timar, T. Preparation and fungicidal activity of 5-substituted hydantoins and their 2-thio analogs. J. Agric. Food Chem. 1993, 41, 148–152. [Google Scholar] [CrossRef]
  14. Bucherer, H.T.; Lieb, V.A. About the formation of substituted hydantoine from aldehydes and ketones—Synthesis of hydantoin (II announcement). J. Prakt. Chem. 1934, 141, 5–43. [Google Scholar] [CrossRef]
  15. Urech, F. XXI. Ueber Lacturaminsäure und Lactylharnstoff. Liebigs Ann. 1873, 165, 99–103. [Google Scholar] [CrossRef]
  16. Biltz, H. Über die Konstitution der Einwirkungsprodukte von substituierten Harnstoffen auf Benzil und über einige neue Methoden zur Darstellung der 5.5-Diphenyl-hydantoine. Ber. Dtsch. Chem. Ges. 1908, 41, 1379–1393. [Google Scholar] [CrossRef]
  17. Ware, E. The Chemistry of the Hydantoins. Chem. Rev. 1950, 46, 403–470. [Google Scholar] [CrossRef] [PubMed]
  18. López, C.A.; Trigo, G.G. The Chemistry of Hydantoins. Adv. Heterocycl. Chem. 1985, 38, 177–228. [Google Scholar] [CrossRef]
  19. Meusel, M.; Gütschow, M. Recent Developments in Hydantoin Chemistry. A Review. Org. Prep. Proced. Int. 2004, 36, 391–443. [Google Scholar] [CrossRef]
  20. Konnert, L.; Lamaty, F.; Martínez, J.; Colaciano, E. Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. Chem. Rev. 2017, 117, 13757–13809. [Google Scholar] [CrossRef]
  21. Hulme, C.; Bienaymé, H.; Nixey, T.; Chenera, B.; Jones, W.; Tempest, P.; Smith, A.L. Library Generation via Postcondensation Modifications of Isocyanide-Based Multicomponent Reactions. Methods Enzym. 2003, 369, 469–496. [Google Scholar] [CrossRef]
  22. Cioc, R.C.; Ruijter, E.; Orru, R.V.A. Multicomponent reactions: Advanced tools for sustainable organic synthesis. Green Chem. 2014, 16, 2958–2975. [Google Scholar] [CrossRef]
  23. Kotha, S.; Gupta, N.K.; Aswar, V.R. Multicomponent Approach to Hydantoins and Thiohydantoins Involving a Deep Eutectic Solvent. Chem. Asian, J. 2019, 14, 3188–3197. [Google Scholar] [CrossRef]
  24. Slobbe, P.; Ruijter, E.; Orru, R.V.A. Recent applications of multicomponent reactions in medicinal chemistry. Med. Chem. Commun. 2012, 3, 1189–1218. [Google Scholar] [CrossRef]
  25. Zhu, J.; Wang, Q.; Wang, M.-X. Multicomponent Reactions in Organic Synthesis; Wiley-VCH: Weinheim, Germany, 2015. [Google Scholar]
  26. Müller, T.J.J. Science of Synthesis, Multicomponent Reactions, Vol 1 and 2; Thieme: Stutgart, Germany, 2014. [Google Scholar]
  27. Palacios, F.; Vicario, J.; Aparicio, D. An efficient synthesis of achiral and chiral cyclic dehydro-α-amino acid derivatives through nucleophilic addition of Amines to β,γ-unsaturated α-keto esters. Eur. J. Org. Chem. 2006, 2006, 2843–2850. [Google Scholar] [CrossRef]
  28. del Corte, X.; Maestro, A.; Vicario, J.; Martínez de Marigorta, E.; Palacios, F. Brönsted-Acid-Catalyzed Asymmetric Three-Component Reaction of Amines, Aldehydes, and Pyruvate Derivatives. Enantioselective Synthesis of Highly Functionalized γ-Lactam Derivatives. Org. Lett. 2018, 20, 317–320. [Google Scholar] [CrossRef] [PubMed]
  29. del Corte, X.; Martínez de Marigorta, E.; Palacios, F.; Vicario, J. A Brønsted Acid-Catalyzed Multicomponent Reaction for the Synthesis of Highly Functionalized γ-Lactam Derivatives. Molecules 2019, 24, 2951. [Google Scholar] [CrossRef]
  30. del Corte, X.; López-Francés, A.; Maestro, A. Martínez de Marigorta, E.; Palacios, F.; Vicario. J. Brönsted Acid Catalyzed Multicomponent Synthesis of Phosphorus and Fluorine-Derived γ-Lactam Derivatives. J. Org. Chem. 2020, 85, 14369–14383. [Google Scholar] [CrossRef]
Figure 1. Structure of anticonvulsant hydantoins.
Figure 1. Structure of anticonvulsant hydantoins.
Molbank 2021 m1218 g001
Scheme 1. Traditional synthesis of hydantoins.
Scheme 1. Traditional synthesis of hydantoins.
Molbank 2021 m1218 sch001
Scheme 2. Three-component synthesis of hydantoin 4.
Scheme 2. Three-component synthesis of hydantoin 4.
Molbank 2021 m1218 sch002
Figure 2. X-ray structure of hydantoin 4 (S enantiomer shown).
Figure 2. X-ray structure of hydantoin 4 (S enantiomer shown).
Molbank 2021 m1218 g002
Scheme 3. Proposed pathway for the formation of hydantoin 4.
Scheme 3. Proposed pathway for the formation of hydantoin 4.
Molbank 2021 m1218 sch003
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Back to TopTop